Skip to content
 
Business Development
 
At Synovathera, our business development approach is focused on building strong, collaborative partnerships across the healthcare ecosystem. We work closely with industry leaders, government agencies, advocacy groups, key opinion leaders, academic institutions, and clinical organizations to drive innovation and ensure groundbreaking therapies reach the market—and the patients who need them most. Through flexible licensing, marketing and commercialization opportunities, we empower companies to expand their impact. Synovathera navigates complex regulatory pathways, advocates for patient needs, and brings your innovation to market with success.
 
Strategy

We focus on commercializing products not yet launched in Canada, new unique medications and late-stage market-ready products. Our approach prioritizes:
  • Solutions that address unmet needs in Canadian healthcare.
  • Offerings that provide value to patients and healthcare professionals.
  • Opportunities that align with our internal synergies.
  • Products that support creative marketing strategies.
Our goal is to help bring life-changing therapies to market, ensuring your innovations make a real impact.
 
pexels-jakubzerdzicki-21299740

Sales and Marketing

Our dedicated sales and marketing team, with extensive product launch experience, collaborates closely with healthcare professionals to increase brand visibility and product adoption in the Canadian market.

Therapeutic Areas 

  • Focused Expertise in High-Impact Therapeutic Areas
  • Alzheimers, Rare Disease, CNS, Oncology, Specialty and more

pexels-sora-shimazaki-5668859-1
Market Access
 

Synovathera leverages extensive experience in Canadian reimbursement to ensure streamlined market access for our partners. Skilled in navigating key agencies like CADTH, INESSS, PMPRB, and pCPA, we support our partners at every step—from regulatory and pricing compliance to securing positive assessments.

Our team has a strong track record of successful launch prices and favourable reimbursement outcomes. Synovathera delivers the strategic support necessary to achieve optimal pricing, broad coverage, and sustained market success for therapies in Canada.

 
compliance-5899190_1280

Regulatory

Synovathera expertly navigates Canada’s regulatory and compliance landscape, ensuring products meet high standards for safety, efficacy, and quality. Our team is well-versed in Health Canada and PMPRB requirements, guiding partners through regulatory submissions, post-market surveillance, and strict compliance practices. By staying updated on regulatory changes, Synovathera mitigates risks and streamlines approvals, creating an efficient pathway for bringing innovations to the Canadian market.

Learn More
compliance-5899194_1280